Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Current Medical Research and Opinion|January 4, 2011
A clinical and economic evaluation of enteral nutritionMichael J Cangelosi, Hannah R Auerbach, Joshua T Cohen
Health Policy (Amsterdam, Netherlands)|December 16, 2014
Medicare's use of cost-effectiveness analysis for prevention (but not for treatment)James D Chambers, Michael J Cangelosi, Peter J Neumann
Respiration; International Review of Thoracic Diseases|June 8, 2023
Sampling of Thoracic Lymph Nodes and Lung Lesions: Trends in Procedural UtilizationMomen M Wahidi, Sonia Lee, Geri R Cramer, et al.
JPEN. Journal of Parenteral and Enteral Nutrition|December 10, 2013
Evaluation of the economic burden of diseases associated with poor nutrition statusMichael J Cangelosi, Angie Mae Rodday, Tully Saunders, et al.
The American Journal of Managed Care|October 9, 2014
Potential role of network meta-analysis in value-based insurance designJames D Chambers, Aaron Winn, Yue Zhong, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 17, 2013
Willingness to pay for diagnostic technologies: a review of the contingent valuation literaturePei-Jung Lin, Michael J Cangelosi, David W Lee, et al.
International Journal of Technology Assessment in Health Care|January 12, 2016
CHANGING FACE OF MEDICARE'S NATIONAL COVERAGE DETERMINATIONS FOR TECHNOLOGYJames D Chambers, Matthew D Chenoweth, Junhee Pyo, et al.
Pancreas|April 10, 2024
Clinical and Economic Implications of Interventions in Pancreatic Fluid Collections: An Assessment From a National Claims DatabaseShyam Varadarajulu, Michael J Cangelosi, Geri R Cramer, et al.
Health Affairs (Project Hope)|February 4, 2015
Medicare is scrutinizing evidence more tightly for national coverage determinationsJames D Chambers, Matthew Chenoweth, Michael J Cangelosi, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|July 15, 2017
Indirect comparison of bronchial thermoplasty versus omalizumab for uncontrolled severe asthmaRobert M Niven, Michael R Simmonds, Michael J Cangelosi, et al.
Pageof 2